Overtreatment of men with early‐stage prostate cancer and limited life expectancy

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|23|3592-3594

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.23, 2014-12, pp. : 3592-3594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Variation in treatment associated with life expectancy in a population‐based cohort of men with early‐stage prostate cancer

By  

CANCER, Vol. 120, Iss. 23, 2014-12 ,pp. : 3642-3650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expectant management for men with early stage prostate cancer

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 4, 2015-07 ,pp. : 264-282

John Wiley & Sons Inc

Access to resources Recommend Favorite

Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early‐stage prostate cancer

By  

CANCER, Vol. 119, Iss. 19, 2013-10 ,pp. : 3446-3453

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative effectiveness of aggressive versus nonaggressive treatment among men with early‐stage prostate cancer and differing comorbid disease burdens at diagnosis

By  

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2432-2439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of early‐stage prostate cancer among rural and urban patients

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 3067-3075

John Wiley & Sons Inc

Access to resources Recommend Favorite